Microbial activation of gut Dendritic cells and the control of mucosal immunity

Journal of Interferon and Cytokine Research

Volumn 33, Issue 11, 2013, Pages 619-631

  Owen, Jennifer L ^a   Mohamadzadeh, Mansour ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; PROBIOTIC AGENT; RETINOIC ACID; RETINOL; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ATOPIC DERMATITIS; BIFIDOBACTERIALES; CELL INTERACTION; DENDRITIC CELL; ENTERITIS; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE FLORA; LACTOBACILLUS; MICROBIAL DIVERSITY; MUCOSAL IMMUNITY; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYMBIOSIS; T LYMPHOCYTE; ANIMAL; CYTOLOGY; IMMUNOLOGY; INTESTINE MUCOSA; MICROBIOLOGY;

ENTEROBACTERIACEAE;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA;

EID: 84887035867     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0046     Document Type: Review

References (128)

1. Abraham C, Medzhitov R. 2011. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140(6):1729-1737.
2. Abreu MT. 2010. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10(2):131-144.
3. Andrews JM, Tan M. 2012. Probiotics in luminal gastroenterology: the current state of play. Int Med J 42(12):1287-1291.
4. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C. 2012. Intestinal inflammation targets cancerinducing activity of the microbiota. Science 338(6103):120-123.
5. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, Antolin M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A,Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama- Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Merieux A, Melo Minardi R, MRini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P. 2011. Enterotypes of the human gut microbiome. Nature 473(7346):174-180.
6. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190(7):995-1004.
7. Bar-On L, Zigmond E, Jung S. 2011. Management of gut inflammationthrough the manipulation of intestinal dendritic cells and macrophages? Semin Immunol 23(1):58-64.
8. Barengolts E. 2013. Vitamin D and prebiotics may benefit the intestinal microbacteria and improve glucose homeostasis in prediabetes and type 2 diabetes. Endocr Pract 19(3):497-510.
9. Belz GT, Nutt SL. 2012. Transcriptional programming of the dendritic cell network. Nat Rev Immunol 12(2):101-113.
10. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. 2005. VSL#3 probioticmixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100(7):1539-1546.
11. Blasius AL, Beutler B. 2010. Intracellular toll-like receptors. Immunity 32(3):305-315.
12. Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, Ham S, Sandall BP, Khan MW, Mahvi DM, Halverson AL, Stryker SJ, Boller A-M, Singal A, Sneed RK, Sarraj B, Ansari MJ, Oft M, Iwakura Y, Zhou L, Bonertz A, Beckhove P, Gounari F, Khazaie K. 2012. Expression of RORgt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer. Sci Trans Med 4(164):164ra159
13. Booijink CC, El-Aidy S, Rajilic-Stojanovic M, Heilig HG, Troost FJ, Smidt H, Kleerebezem M, De Vos WM, Zoetendal EG. 2010. High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol 12(12):3213-3227.
14. Bron PA, van Baarlen P, Kleerebezem M. 2012. Emerging molecularinsights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10(1):66-78.
15. Capelluto DG. 2012. Tollip: a multitasking protein in innate immunity and protein trafficking. Microbes Infect 14(2):140-147.
16. Cario E. 2010. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 16(9):1583-1597.
17. Cerovic V, Jenkins CD, Barnes AG, Milling SW, MacPherson GG, Klavinskis LS. 2009. Hyporesponsiveness of intestinal dendritic cells to TLR stimulation is limited to TLR4. J Immunol 182(4):2405-2415.
18. Chae CS, Kwon HK, Hwang JS, Kim JE, Im SH. 2012. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis. PloS One 7(12):e52119.
19. Chang HC, Lin KH, Tai YT, Chen JT, Chen RM. 2010. Lipoteichoic acid-induced TNF-A and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating Toll-like receptor 2-mediated activation oF ERK1/2 and NFkB. Shock 33(5):485-492.
20. Chang SY, Song JH, Guleng B, Cotoner CA, Arihiro S, Zhao Y, Chiang HS, OKeeffe M, Liao G, Karp CL, Kweon MN, Sharpe AH, Bhan A, Terhorst C, Reinecker HC. 2013. Circulatory antigen processing by mucosal dendritic cells controls CD8( + ) T cell activation. Immunity 38(1):153-165.
21. Chassaing B, Darfeuille-Michaud A. 2011. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140(6):1720-1728.
22. Christensen HR, Frokiaer H, Pestka JJ. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168(1):171-178.
23. Coombes JL, Maloy KJ. 2007. Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin Immunol 19(2):116-126.
24. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. 2007. A functionally specialized population of mucosal CD103 + DCs induces Foxp3 + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204(8):1757-1764.
25. Curotto de Lafaille MA, Lafaille JJ. 2009. Natural and adaptive foxp3 + regulatory T cells: more of the same or a division of labor? Immunity 30(5):626-635.
26. DSouza A, Cai CL, Kumar D, Cai F, Fordjour L, Ahmad A, Valencia G, Aranda JV, Beharry KD. 2012. Cytokines and Tolllike receptor signaling pathways in the terminal ileum of hypoxic/hyperoxic neonatal rats: benefits of probiotics supplementation. Am J Trans Res 4(2):187-197.
27. Dai C, Zheng CQ, Meng FJ, Zhou Z, Sang LX, Jiang M. 2013. VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-kappaB pathway in rat model of DSS-induced colitis. Mol Cell Biochem 374(1-2):1-11.
28. Deshpande G, Rao S, Patole S, Bulsara M. 2010. Updated metaanalysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125(5):921-930.
29. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. 2012. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487(7405):104-108.
30. Diehl GE, Longman RS, Zhang JX, Breart B, Galan C, Cuesta A,Schwab SR, Littman DR. 2013. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 494(7435):116-120.
31. Dongarra ML, Rizzello V, Muccio L, Fries W, Cascio A, Bonaccorsi I, Ferlazzo G. 2013. Mucosal immunology and probiotics. Curr Allergy Asthma Rep 13(1):19-26.
32. Evrard B, Coudeyras S, Dosgilbert A, Charbonnel N, Alame J, Tridon A, Forestier C. 2011. Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PloS One 6(4):e18735.
33. Feehley T, Stefka AT, Cao S, Nagler CR. 2012. Microbial regulation of allergic responses to food. Semin Immunopathol 34(5): 671-688.
34. Fujimoto K, Karuppuchamy T, Takemura N, Shimohigoshi M, Machida T, Haseda Y, Aoshi T, Ishii KJ, Akira S, Uematsu S. 2011. A new subset of CD103 + CD8alpha + dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity. J Immunol 186(11): 6287-6295.
35. Fumagalli M, Sironi M, Pozzoli U, Ferrer-Admetlla A, Pattini L, Nielsen R. 2011. Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet 7(11):e1002355.
36. Gad M, Ravn P, Soborg DA, Lund-Jensen K, Ouwehand AC, Jensen SS. 2011. Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria. FEMS Immunol Med Microbiol 63(1):93-107.
37. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355-1359.
38. Gologan S, Iacob R, Iancu D, Iacob S, Cotruta B, Vadan R, Catuneanu AM, Constantinescu I, Barbarii L, Gheorghe C, Diculescu M. 2012. Inflammatory gene expression profiles in Crohns disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol. J Crohns Colitis [Epub ahead of print]; DOI: 10.1016/j.crohns.2012.08.015.
39. Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A. 2005. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 102(29):10321-10326.
40. Guarner F. 2005. The intestinal flora in inflammatory bowel disease: normal or abnormal? Curr Opin Gastroenterol 21(4):414-418.
41. Guarner F, Schaafsma GJ. 1998. Probiotics. Int J Food Microbiol 39(3):237-238.
42. Hadis U, Wahl B, Schulz O, Hardtke-Wolenski M, Schippers A, Wagner N, Muller W, Sparwasser T, orster R, Pabst O. 2011. Intestinal tolerance requires gut homing and expansion of FoxP3 + regulatory T cells in the lamina propria. Immunity 34(2):237-246.
43. Hakansson A, Molin G. 2011. Gut microbiota and inflammation. Nutrients 3(6):637-682.
44. Hammer GE, Ma A. 2013. Molecular control of steady-state dendritic cell maturation and immune homeostasis. Ann Rev Immunol 31:743-791.
45. Haribhai D, Lin W, Edwards B, Ziegelbauer J, Salzman NH, Carlson MR, Li SH, Simpson PM, Chatila TA, Williams CB. 2009. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J Immunol 182(6): 3461-3468.
46. Honda K, Littman DR. 2012. The microbiome in infectious disease and inflammation. Ann Rev Immunol 30:759-795.
47. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. 2011. Characterization of interleukin-17-producing regulatory cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140(3):957-965.
48. Hume DA. 2008. Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol 1(6): 432-441.
49. Jang MH, Sougawa N, Tanaka T, Hirata T, Hiroi T, Tohya K, Guo Z, Umemoto E, Ebisuno Y, Yang BG, Seoh JY, Lipp M, Kiyono H, Miyasaka M. 2006. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol 176(2):803-810.
50. Jeffery IB, Claesson MJ, OToole PW, Shanahan F. 2012. Categorization of the gut microbiota: enterotypes or gradients? Nat Rev Microbiol 10(9):591-592.
51. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K. 2012. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathogens 8(5):e1002714.
52. Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, De Simone C, Madsen K. 2004. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126(5):1358-1373.
53. Kaji R, Kiyoshima-Shibata J, Nagaoka M, Nanno M, Shida K. 2010. Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 184(7):3505-3513.
54. Kang SS, Ryu YH, Baik JE, Yun CH, Lee K, Chung DK, Han SH. 2011. Lipoteichoic acid from Lactobacillus plantarum induces nitric oxide production in the presence of interferon- g in murine macrophages. Mol Immunol 48(15-16):2170-2177.
55. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. 2005. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115(3):695-702.
56. Kawai T, Akira S. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34(5):637-650.
57. Kelly D, Mulder IE. 2012. Microbiome and immunological interactions. Nutr Rev 70 Suppl 1:S18-S30.
58. Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM. 2009. Lower Bifidobacteria counts in both duodenal mucosa-Associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 15(23):2887-2892.
59. Khan MW, Zadeh M, Bere P, Gounaris E, Owen J, Klaenhammer T, Mohamadzadeh M. 2012. Modulating intestinal immune responses by lipoteichoic acid-deficient Lactobacillus acidophilus. Immunotherapy 4(2):151-161.
60. Khazaie K, Zadeh M, Khan MW, Bere P, Gounari F, Dennis K, Blatner NR, Owen JL, Klaenhammer TR, Mohamadzadeh M. 2012. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S 109(26):10462-10467.
61. King TS, Elia M, Hunter JO. 1998. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 352(9135):1187-1189.
62. Kinnebrew MA, Pamer EG. 2012. Innate immune signaling in defense against intestinal microbes. Immunol Rev 245(1):113-131.
63. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, Molle D, Lortal S, Altermann E, Klaenhammer TR, van Kooyk Y. 2008. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 105(49):19474-19479.
64. Kubinak JL, Round JL. 2012. Toll-like receptors promote mutually beneficial commensal-host interactions. PLoS Pathogens 8(7):e1002785.
65. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH. 2010. Generation of regulatory dendritic cells and CD4 + Foxp3 + T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107(5):2159-2164.
66. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, Peterson DA, Stappenbeck TS, Hsieh CS. 2011. Peripheral education of the immune system by colonic commensal microbiota. Nature 478(7368):250-254.
67. Lavelle EC, Murphy C, ONeill LA, Creagh EM. 2010. The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 3(1):17-28.
68. Lebeer S, Claes IJ, Vanderleyden J. 2012. Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol 20(1):5-10.
69. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff M, Eckmann L, Ben-Neriah Y, Raz E. 2006. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8(12):1327-1336.
70. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4):837-848.
71. Lilly DM, Stillwell RH. 1965. Probiotics: growth-promoting factors produced by microorganisms. Science 147(3659):747-748.
72. Macho Fernandez E, Valenti V, Rockel C, Hermann C, Pot B, Boneca IG, Grangette C. 2011. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2- mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60(8):1050-1059.
73. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang YC, Pulendran B. 2010. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329(5993):849-853.
74. Martinez-Pomares L. 2012. The mannose receptor. J Leukoc Biol 92(6):1177-1186.
75. Mayer CT, Berod L, Sparwasser T. 2012. Layers of dendritic cellmediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol 3:183.
76. Medani M, Collins D, Docherty NG, Baird AW, OConnell PR, Winter DC. 2011. Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm Bowel Dis 17(7): 1620-1625.
77. Meijer BJ, Dieleman LA. 2011. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol 45 Suppl:S139-S144.
78. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR. 2005. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 102(8):2880-2885.
79. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, Bere P, Sarraj B, Khan MW, Pakanati KC, Ansari MJ, OFlaherty S, Barrett T, Klaenhammer TR. 2011. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 108 Suppl 1:4623-4630.
80. Molenaar R, Knippenberg M, Goverse G, Olivier BJ, de Vos AF, OToole T, Mebius RE. 2011. Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gutdraining lymph node stromal cells is controlled by dietary vitamin A. J Immunol 186(4):1934-1942.
81. Molloy MJ, Bouladoux N, Belkaid Y. 2012. Intestinal microbiota: shaping local and systemic immune responses. Semin Immunol 24(1):58-66.
82. Monroe KM, McWhirter SM, Vance RE. 2010. Induction of typei interferons by bacteria. Cell Microbiol 12(7):881-890.
83. Mottet C, Uhlig HH, Powrie F. 2003. Cutting edge: cure of colitis by CD4 + CD25 + regulatory T cells. J Immunol 170(8):3939-3943.
84. Niess JH, Adler G. 2010. Enteric flora expands gut lamina propria CX3CR1 + dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions. J Immunol 184(4):2026-2037.
85. Nilsen NJ, Deininger S, Nonstad U, Skjeldal F, Husebye H, Rodionov D, von Aulock S, Hartung T, Lien E, Bakke O, Espevik T. 2008. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J Leukoc Biol 84(1):280-291.
86. Nishio J, Honda K. 2012. Immunoregulation by the gut microbiota. Cell Mol Life Sci 69(21):3635-3650.
87. OShea EF, Cotter PD, Stanton C, Ross RP, Hill C. 2012. Production of bioactive substances by intestinal bacteria as basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol 152(3):189-205.
88. Pabst O, Bernhardt G. 2010. The puzzle of intestinal lamina propria dendritic cells and macrophages. Eur J Immunol 40(8):2107-2111.
89. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, Servillo G, Brunacci C, Calvitti M, Bicciato S, Mazza EM, Boon L, Grassi F, Fioretti MC, Fallarino F, Puccetti P, Grohmann U. 2011. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12(9):870-878.
90. Qian C, Jiang X, An H, Yu Y, Guo Z, Liu S, Xu H, Cao X. 2006. TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to Nkcell activation. Blood 108(7):2307-2315.
91. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, Takabayashi K, Raz E. 2004. Toll-like receptor 9 signaling mediates the antiinflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126(2):520-528.
92. Ramalingam R, Larmonier CB, Thurston RD, Midura-Kiela MT, Zheng SG, Ghishan FK, Kiela PR. 2012. Dendritic cell-specific disruption of TGF-beta receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity. J Immunol 189(8):3878-3893.
93. Reichmann NT, Gru ndling A. 2011. Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. FEMS Microbiol Lett 319(2):97-105.
94. Reiff C, Kelly D. 2010. Inflammatory bowel disease, gut bacteria and probiotic therapy. International journal of medical microbiology: IJMM 300(1):25-33.
95. Rescigno M. 2011. Dendritic cells in bacteria handling in the gut. J Leukoc Biol 90(4):669-672.
96. Ronnblom L, Eloranta ML. 2013. The interferon signature in autoimmune diseases. Curr Opin Rheumatol 25(2): 248-253.
97. Ruane DT, Lavelle EC. 2011. The role of CD103( + ) dendritic cells in the intestinal mucosal immune system. Front Immunol 2:25.
98. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WR, Muller W, Rudensky AY. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546-558.
99. Saber R, Zadeh M, Pakanati KC, Bere P, Klaenhammer T, Mohamadzadeh M. 2011. Lipoteichoic acid-deficient Lactobacillus acidophilus regulates downstream signals. Immunotherapy 3(3):337-347.
100. Sanders ME. 2011. Impact of probiotics on colonizing microbiota of the gut. J Clin Gastroenterol 45 Suppl:S115-S119.
101. Schiavi E, Barletta B, Butteroni C, Corinti S, Boirivant M, Di Felice G. 2011. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy 66(4): 499-508.
102. Sekirov I, Russell SL, Antunes LC, Finlay BB. 2010. Gut microbiota in health and disease. Physiol Rev 90(3):859-904.
103. Shanahan F. 2012. The colonic microbiota and colonic disease. Curr Gastroenterol Rep 14(5):446-452.
104. Smelt MJ, de Haan BJ, Bron PA, van Swam I, Meijerink M, Wells JM, Faas MM, de Vos P. 2012. L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner. PloS One 7(10):e47244.
105. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML. 2005. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115(6):1260-1267.
106. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PloS One 6(1):e16393.
107. Stock A, Napolitani G, Cerundolo V. 2013. Intestinal DC in migrational imprinting of immune cells. Immunol Cell Biol 91(3):240-249.
108. Swiatczak B, Rescigno M. 2012. How the interplay between antigen presenting cells and microbiota tunes host immune responses in the gut. Semin Immunol 24(1):43-49.
109. Takahashi M, Nakamura K, Honda K, Kitamura Y, Mizutani T, Araki Y, Kabemura T, Chijiiwa Y, Harada N, Nawata H. 2006. An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig Dis Sci 51(4):677-686.
110. Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C. 2004. Crohns disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127(1):365-366.
111. Tsai YT, Cheng PC, Pan TM. 2012. The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96(4):853-862.
112. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. 2009. A core gut microbiome in obese and lean twins. Nature 457(7228): 480-484.
113. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M, Sato S, Tsujimura T, Yamamoto M, Yokota Y, Kiyono H, Miyasaka M, Ishii KJ, Akira S. 2008. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol 9(7):769-776.
114. van Baarlen P, Troost F, van der Meer C, Hooiveld G, Boekschoten M, Brummer RJ, Kleerebezem M. 2011. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 108 Suppl 1:4562-4569.
115. van Belkum A, Nieuwenhuis EE. 2007. Life in commercial probiotics.FEMS Immunol Med Microbiol 50(3):281-283.
116. Vanderpool C, Yan F, Polk DB. 2008. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 14(11):1585-1596.
117. Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, Fehling HJ, Hardt WD, Shakhar G, Jung S. 2009. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31(3):502-512.
118. Varol C, Zigmond E, Jung S. 2010. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nat Rev Immunol 10(6):415-426.
119. Veerappan GR, Betteridge J, Young PE. 2012. Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep 14(4):324-333.
120. Walsh D, McCarthy J, ODriscoll C, Melgar S. 2013. Pattern recognition receptors-molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev 24(2):91-104.
121. Weiss G, Christensen HR, Zeuthen LH, Vogensen FK, Jakobsen M, Frokiaer H. 2011. Lactobacilli and bifidobacteria induce differential interferon-beta profiles in dendritic cells. Cytokine 56(2):520-530.
122. Weiss G, Rasmussen S, Nielsen Fink L, Jarmer H, Nohr Nielsen B, Frokiaer H. 2010. Bifidobacterium bifidum actively changes the gene expression profile induced by Lactobacillus acidophilus in murine dendritic cells. PloS One 5(6):e11065.
123. Whitman WB, Coleman DC, Wiebe WJ. 1998. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 95(12):6578-6583.
124. Wing JB, Sakaguchi S. 2012. Multiple treg suppressive modules and their adaptability. Front Immunol 3:178
125. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105-108.
126. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, Anthony BA, Sverdrup FM, Head R, Kuster DJ, Ruminski P, Weiss D, Von Schack D, Bluestone JA. 2012. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 209(10):1713-1722, S1-S19.
127. Yan F, Polk DB. 2011. Probiotics and immune health. Curr Opin Gastroenterol 27(6):496-501.
128. Zassadowski F, Rochette-Egly C, Chomienne C, Cassinat B. 2012. Regulation of the transcriptional activity of nuclear receptors by the MEK/ERK1/2 pathway. Cell Signal 24(12): 2369-2377.